Maximus, Inc. (NYSE:MMS) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 86.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,438 shares of the health services provider's stock after selling 62,494 shares during the period. Jane Street Group LLC's holdings in Maximus were worth $705,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of MMS. IFP Advisors Inc raised its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after buying an additional 302 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Maximus during the fourth quarter valued at approximately $1,113,000. Legato Capital Management LLC raised its position in shares of Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after buying an additional 8,138 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock worth $54,748,000 after purchasing an additional 16,772 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after acquiring an additional 71,598 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Stock Down 1.1%

Shares of MMS traded down $0.81 during mid-day trading on Thursday, hitting $71.83. 276,360 shares of the company traded hands, compared to its average volume of 561,196. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The business has a 50 day moving average of $69.70 and a 200 day moving average of $71.94. The company has a market capitalization of $4.05 billion, a PE ratio of 15.45 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the company earned $1.57 EPS. The company's revenue for the quarter was up 1.0% on a year-over-year basis. Equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.67%. Maximus's dividend payout ratio is currently 23.86%.

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.60% of the company's stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.